1 active not recruiting. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Active not recruiting 1 |
Follow Hemangiosarcoma: new trials by email Literature Review of Hemangiosarcoma trials Research Report on Hemangiosarcoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Fc-Engineered Anti-CTLA-4 Monoclonal Antibody in Advanced Cancer Botensilimab, Balstilimab - Advanced Cancer, Angiosarcoma | Phase 1 | Active not recruiting | Agenus Inc. | 499 | 2019-03-20 | 2026-03-30 |
Carcinoma, Non-Small-Cell Lung (1) · Endometrial Neoplasms (1) · Fibrolamellar hepatocellular carcinoma (1) · Ovarian Neoplasms (1) · Prostatic Neoplasms (1)
Adnexal Diseases (1) · Bronchial Neoplasms (1) · Carcinoma, Bronchogenic (1) · Endocrine Gland Neoplasms (1) · Endocrine System Diseases (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Genital Diseases (1) · Genital Diseases, Female (1) · Genital Diseases, Male (1) · Genital Neoplasms, Female (1) · Genital Neoplasms, Male (1) · Gonadal Disorders (1) · Lung Diseases (1) · Lung Neoplasms (1)
Ipilimumab (1) · balstilimab (1) · spartalizumab (1)
Agenus Inc. (1)
United Kingdom (1) · United States (1)